ID
11715
Descripción
This study will compare the effect of a prasugrel 10-mg maintenance dose with a clopidogrel 75-mg maintenance dose on platelet activity, approximately 1 week after the first dose of study drug, in subjects who have been taking clopidogrel 75 mg daily following a percutaneous coronary intervention (PCI) with placement of a stent, performed to treat acute coronary syndrome (ACS). https://clinicaltrials.gov/ct2/show/NCT00356135
Link
https://clinicaltrials.gov/ct2/show/NCT00356135
Palabras clave
Versiones (1)
- 28/7/15 28/7/15 -
Subido en
28 de julio de 2015
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility SWAP Acute Coronary Syndrome NCT00356135
Eligibility Criteria
- StudyEvent: ODM
Descripción
Exclusion Criteria
Descripción
Left main coronary artery stent
Tipo de datos
boolean
Alias
- UMLS CUI-1
- N
Descripción
left anterior descending (LAD) bifurcation stent
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C3836455
Descripción
Have any form of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) planned to occur during the study (from signing consent through the final visit).
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C1532338
Descripción
Have any form of coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]) planned to occur during the study (from signing consent through the final visit).
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0010055
Descripción
Receiving or will receive oral anticoagulation (other than aspirin and clopidogrel) that cannot be safely discontinued for the duration of the study.
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0354604
Descripción
Receiving or will receive other antiplatelet therapy (other than aspirin and clopidogrel) that cannot be safely discontinued for the duration of the study.
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C1096021
Descripción
Receiving daily treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) that cannot be discontinued or are anticipated to require daily treatment with NSAIDs during the study.
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0003211
Descripción
history of ischemic or hemorrhagic stroke
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0559159
Descripción
Intracranial neoplasm
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C1527390
Descripción
Arteriovenous malformation
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0003857
Descripción
Aneurysm
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0002940
Descripción
History of transient ischemic attack (TIA)
Tipo de datos
boolean
Alias
- UMLS CUI-1
- C0455536
Descripción
Have a body weight less than 60 kilograms (kg)
Tipo de datos
boolean
Similar models
Eligibility Criteria
- StudyEvent: ODM